Cite
HARVARD Citation
Sweet, D. et al. (2022). A first-in-human clinical study of a new SP-B and SP-C enriched synthetic surfactant (CHF5633) in preterm babies with respiratory distress syndrome: two-year outcomes. Journal of maternal-fetal & neonatal medicine. pp. 4739-4742. [Online].